Summary
Methylmalonic acidaemia (MMA) is a genetic disorder caused by defects in methylmalonyl-CoA mutase or in any of the different proteins involved in the synthesis of adenosylcobalamin. The aim of this work was to examine the biochemical and clinical phenotype of 32 MMA patients according to their genotype, and to study the mutant mRNA stability by real-time PCR analysis. Using cellular and biochemical methods, we classified our patient cohort as having the MMA forms mut (n = 19), cblA (n = 9) and cblB (n = 4). All the mut 0 and some of the cblB patients had the most severe clinical and biochemical manifestations, displaying non-inducible propionate incorporation in the presence of hydroxocobalamin (OHCbl) in vitro and high plasma odd-numbered long-chain fatty acid (OLCFA) concentrations under dietary therapy. In contrast, mut − and cblA patients exhibited a milder phenotype with propionate incorporation enhanced by OHCbl and normal OLCFA levels under dietary therapy. No missense mutations identified in the MUT gene, including mut 0 and mut − changes, affected mRNA stability. A new sequence variation (c.562G>C) in the MMAA gene was identified. Most of the cblA patients carried premature termination codons (PTC) in both alleles. Interestingly, the transcripts containing the PTC mutations were insensitive to nonsense-mediated decay (NMD).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Acquaviva C, Benoist JF, Pereira S, et al (2005) Molecular basis of methylmalonyl-CoA mutase apoenzyme defect in 40 European patients affected by mut0 and mut− forms of methylmalonic acidemia: identification of 29 novel mutations in the MUT gene. Hum Mutat 25: 167–176.
Chuang JL, Wynn RM, Moss CC, et al (2004) Structural and biochemical basis for novel mutations in homozygous Israeli maple syrup urine disease patients: a proposed mechanism for the thiamin-responsive phenotype. J Biol Chem 279: 17792–17800.
Coker M, de Klerk JB, Poll-The BT, Huijmans JG, Duran M (1996) Plasma total odd-chain fatty acids in the monitoring of disorders of propionate, methylmalonate and biotin metabolism. J Inherit Metab Dis 19: 743–751.
Dipple KM, McCabe ER (2000a) Modifier genes convert “simple” Mendelian disorders to complex traits. Mol Genet Metab 71: 43–50.
Dipple KM, McCabe ER (2000b) Phenotypes of patients with “simple” Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics. Am J Hum Genet 66: 1729–1735.
Dobson CM, Wai T, Leclerc D, et al (2002a) Identification of the gene responsible for the cblB complementation group of vitamin B12-dependent methylmalonic aciduria. Hum Mol Genet 11: 3361–3369.
Dobson CM, Wai T, Leclerc D, et al (2002b) Identification of the gene responsible for the cblA complementation group of vitamin B12-responsive methylmalonic acidemia based on analysis of prokaryotic gene arrangements. Proc Natl Acad Sci USA 99: 15554–15559.
Erlandsen H, Pey AL, Gamez A, et al (2004) Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations. Proc Natl Acad Sci USA 101: 16903–16908.
Fenton WA, Gravel RA, Rosenberg LE (2001) Disorders of propionate and methylmalonate metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2165–2190.
Harries LW, Bingham C, Bellanne-Chantelot C, Hattersley AT, Ellard S (2005) The position of premature termination codons in the hepatocyte nuclear factor-1 beta gene determines susceptibility to nonsense-mediated decay. Hum Genet 118: 214–224.
Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik AE (2004) Nonsense-mediated decay approaches the clinic. Nat Genet 36: 801–808.
Inacio A, Silva AL, Pinto J, et al (2004) Nonsense mutations in close proximity to the initiation codon fail to trigger full nonsense-mediated mRNA decay. J Biol Chem 279: 32170–32180.
Janata J, Kogekar N, Fenton WA (1997) Expression and kinetic characterization of methylmalonyl-CoA mutase from patients with the mut− phenotype: evidence for naturally occurring interallelic complementation. Hum Mol Genet 6: 1457–1464.
Korotkova N, Lidstrom ME (2004) MeaB is a component of the methylmalonyl-CoA mutase complex required for protection of the enzyme from inactivation. J Biol Chem 279: 13652–13658.
Ledley FD, Crane AM, Lumetta M (1990) Heterogeneous alleles and expression of methylmalonyl CoA mutase in mut methylmalonic acidemia. Am J Hum Genet 46: 539–547.
Leonard JV (1995) The management and outcome of propionic and methylmalonic acidaemia. J Inherit Metab Dis 18: 430–434.
Leonard JV, Vijayaraghavan S, Walter JH (2003) The impact of screening for propionic and methylmalonic acidaemia. Eur J Pediatr 162(Supplement 1): S21–24.
Lerner-Ellis JP, Dobson CM, Wai T, et al (2004) Mutations in the MMAA gene in patients with the cblA disorder of vitamin B12 metabolism. Hum Mutat 24: 509–516.
Martinez MA, Rincon A, Desviat LR, Merinero B, Ugarte M, Perez B (2005) Genetic analysis of three genes causing isolated methylmalonic acidemia: identification of 21 novel allelic variants. Mol Genet Metab 84: 317–325.
Moras E, Hosack A, Watkins D, Rosenblatt DS (2007) Mitochondrial vitamin B12-binding proteins in patients with inborn errors of cobalamin metabolism. Mol Genet Metab 90: 140–147.
Ogasawara M, Matsubara Y, Mikami H, Narisawa K (1994) Identification of two novel mutations in the methylmalonyl-CoA mutase gene with decreased levels of mutant mRNA in methylmalonic acidemia. Hum Mol Genet 3: 867–872.
Perez-Cerda C, Merinero B, Sanz P, et al (1989) Successful first trimester diagnosis in a pregnancy at risk for propionic acidaemia. J Inherit Metab Dis 12(Supplement 2): 274–276.
Saridakis V, Yakunin A, Xu X, et al (2004) The structural basis for methylmalonic aciduria. The crystal structure of archaeal ATP:cobalamin adenosyltransferase. J Biol Chem 279: 23646–23653.
Schubert HL, Hill CP (2006) Structure of ATP-bound human ATP:cobalamin adenosyltransferase. Biochemistry 45: 15188–15196.
Skandalis A, Uribe E (2004) A survey of splice variants of the human hypoxanthine phosphoribosyl transferase and DNA polymerase beta genes: products of alternative or aberrant splicing? Nucleic Acids Res 32: 6557–6564.
Suormala T, Baumgartner MR, Coelho D, et al (2004) The cblD defect causes either isolated or combined deficiency of methylcobalamin and adenosylcobalamin synthesis. J Biol Chem 279: 42742–42749.
Worgan LC, Niles K, Tirone JC, et al (2006) Spectrum of mutations in mut methylmalonic acidemia and identification of a common Hispanic mutation and haplotype. Hum Mutat 27: 31–43.
Zhang J, Dobson CM, Wu X, Lerner-Ellis J, Rosenblatt DS, Gravel RA (2006) Impact of cblB mutations on the function of ATP:cob(I)alamin adenosyltransferase in disorders of vitamin B12 metabolism. Mol Genet Metab 87: 315–322.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Viktor Kozich
Competing interests: None declared
References to electronic databases: OMIM catalogue number: Methylmalonic acidaemia: OMIM 251000; mut, OMIM 251000; cblA, OMIM 251100; cblB, OMIM 251110; cblD-variant 2, OMIM 277410; cblH, OMIM 606169. Methylmalonyl-CoA mutase: EC 5.4.99.2. ATP:cob(I)alamin adenosyltransferase: EC 2.5.1.17.
The first two authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Merinero, B., Pérez, B., Pérez-Cerdá, C. et al. Methylmalonic acidaemia: Examination of genotype and biochemical data in 32 patients belonging to mut, cblA or cblB complementation group. J Inherit Metab Dis 31, 55–66 (2008). https://doi.org/10.1007/s10545-007-0667-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-007-0667-y